New french questionnaire aims to catch Alzheimer's navigation trouble early

NCT ID NCT07616063

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a French questionnaire designed to identify spatial orientation problems in people with Alzheimer's disease. Researchers will ask 330 participants—including Alzheimer's patients, their caregivers, and healthy older adults—to fill out the questionnaire. The goal is to see if the tool is reliable and useful for spotting early signs of disorientation, which could lead to better care and support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Questionnaire d'Orientation Spatiale (QOS) - a French version of the Wayfinding Questionnaire
What this could lead to
If successful, this questionnaire could become a standard tool to detect spatial disorientation early in Alzheimer's, helping doctors provide better support.
What could go wrong
This is an early-stage validation study, not a treatment trial. The questionnaire may not prove accurate enough for routine use, and results may not apply outside French-speaking populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Orientation, Spatial

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU (Centre Hospitalier Régionale Universitaire) Nancy

    Nancy, 54500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.